Vanguard Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-14,591,103
Closed -$182M 4108
2016
Q4
$182M Buy
14,591,103
+1,462,029
+11% +$18.2M 0.01% 1238
2016
Q3
$180M Buy
13,129,074
+404,675
+3% +$5.54M 0.01% 1193
2016
Q2
$94M Buy
12,724,399
+259,003
+2% +$1.91M 0.01% 1555
2016
Q1
$79.7M Buy
12,465,396
+319,610
+3% +$2.04M 0.01% 1623
2015
Q4
$75.9M Buy
12,145,786
+265,133
+2% +$1.66M 0.01% 1658
2015
Q3
$69.4M Buy
11,880,653
+342,715
+3% +$2M 0.01% 1690
2015
Q2
$95.4M Buy
11,537,938
+364,370
+3% +$3.01M 0.01% 1557
2015
Q1
$92.1M Buy
11,173,568
+437,583
+4% +$3.61M 0.01% 1557
2014
Q4
$73.8M Buy
10,735,985
+300,266
+3% +$2.06M 0.01% 1620
2014
Q3
$56.4M Sell
10,435,719
-220,220
-2% -$1.19M ﹤0.01% 1730
2014
Q2
$67.9M Buy
10,655,939
+271,561
+3% +$1.73M 0.01% 1662
2014
Q1
$83.7M Buy
10,384,378
+48,442
+0.5% +$390K 0.01% 1467
2013
Q4
$70.5M Buy
10,335,936
+379,541
+4% +$2.59M 0.01% 1557
2013
Q3
$183M Buy
9,956,395
+266,050
+3% +$4.9M 0.02% 889
2013
Q2
$169M Buy
+9,690,345
New +$169M 0.02% 858